Medlab receives ‘largest’ cannabis oil shipment for trial | Finance News Network

Medlab receives ‘largest’ cannabis oil shipment for trial

Company News

by Jessica Amir

A leading cannabis company, Aphria, has sent its largest ever cannabis oil export shipment to Medlab Australia (ASX:MDC).

The shipment is part of Medlab’s medical cannabis human trials, to reduce advanced cancer pain.

The Canadian company produces and supplies the high-yield cannabis extracts for Medlab, to test the management of intractable pain oncology patients.

Intractable pain is severe, constant pain not curable, and it’s the first kind of trial to be conducted in the world, according to both companies.  Patient recruitment is currently underway.

Shares in Medlab (ASX:MDC) are trading 4.17 per cent higher at $0.50. 
 

Jessica Amir

Finance News Network
Jessica joined FNN in January 2017 with a passion for equities and funds management. As Head of News, she has been a broadcast journalist for over seven years, specialising in finance. She was a journalist with Sky News Business, ABC 1, ABC's The Business and ABC24. She’s also worked as a TV reporter for Prime 7 and WIN News. Jessica has worked as a financial planner and real estate agent.